Announced Mon, 6 Jul · 12:00 IST
Routine compliance filing under SEBI Regulation 74(5) for Q1 FY27
Compliance View source PDF
LOTUSEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-4.7%1-day move
₹127.25
prior close
₹124.52
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
——-0.3—-4.7-4.9-4.5-7.1-3.2-5.2-6.6———
Up moveDown movePending
AI summary
Lotus Eye Hospital has filed a routine compliance certificate under SEBI Regulation 74(5) for the quarter ended June 30, 2026. The certificate, submitted by their Registrar MUFG Intime India, confirms that all share dematerialisation requests received during the quarter were processed and confirmed to the depositories within prescribed timelines. This is a standard quarterly regulatory requirement.
Likely market impact
Routine administrative compliance filing. No material impact on shareholders or stock price.